Barclays’s Teladoc Health TDOC Stock Holding History

Barclays’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,000	Closed	-$155K	–	5678
2025 Q3	$155K	Hold	20,000	–	–	﹤0.01%	4446
2025 Q2	$174K	Hold	20,000	–	–	﹤0.01%	4367
2025 Q1	$159K	Buy	+20,000	New	+$202K	﹤0.01%	4168
2023 Q1	–	Sell	-29,400	Closed	-$695K	–	5339
2022 Q4	$695K	Buy	+29,400	New	+$793K	﹤0.01%	3076
2022 Q3	–	Sell	-122,500	Closed	-$4.07M	–	5129
2022 Q2	$4.07M	Buy	+122,500	New	+$5.2M	﹤0.01%	1447
2022 Q1	–	Sell	-287,600	Closed	-$26.4M	–	5583
2021 Q4	$26.4M	Buy	+287,600	New	+$34.4M	0.01%	837
2021 Q3	–	Sell	-57,200	Closed	-$9.51M	–	5005
2021 Q2	$9.51M	Sell	57,200 -100,400	-64%	-$16.3M	﹤0.01%	1220
2021 Q1	$28.6M	Buy	157,600 +153,600	+3,840%	+$35.6M	0.02%	653
2020 Q4	$800K	Buy	+4,000	New	+$813K	﹤0.01%	2918
2020 Q1	–	Sell	-1,200	Closed	-$100K	–	6443
2019 Q4	$100K	Sell	1,200 -2,700	-69%	-$205K	﹤0.01%	5479
2019 Q3	$264K	Hold	3,900	–	–	﹤0.01%	4757
2019 Q2	$259K	Hold	3,900	–	–	﹤0.01%	4881
2019 Q1	$217K	Sell	3,900 -2,000	-34%	-$122K	﹤0.01%	4758
2018 Q4	$292K	Buy	+5,900	New	+$361K	﹤0.01%	4305
2018 Q1	–	Sell	-200,000	Closed	-$6.97M	–	7324
2017 Q4	$6.97M	Buy	+200,000	New	+$6.64M	0.01%	1413

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's TDOC Position: Q1 2026 in Review

Barclays reduced its Teladoc Health (TDOC) stake by 63% in Q1 2026, selling an estimated $1.74M and leaving 179,125 shares worth $976K. The position accounts for ﹤0.01% of the portfolio, ranked #2776.

Barclays first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $146M in Q2 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Barclays held 179,125 shares of Teladoc Health worth $976K as of Q1 2026.
Barclays sold 310,857 Teladoc Health shares in Q1 2026, an estimated $1.74M.
Teladoc Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2776 holding.
Barclays first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
Barclays's Teladoc Health position peaked at $146M in Q2 2021.
322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.